semax comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-05-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
Pharmacokinetic accounts emphasize rapid breakdown. After intravenous dosing the intact peptide disappears from blood within minutes, and nasal delivery produces low but measurable concentrations. Metabolites rather than the parent molecule may account for part of the observed activity, although the relative contribution is unresolved. Dosing in the literature varies widely and no optimal schedule has been agreed. These gaps are regularly cited as a reason the findings have not produced broad clinical adoption beyond the original research setting.
Proposed mechanisms center on neurotrophic signaling rather than on classical melanocortin receptor activation. Rodent experiments have reported shifts in the expression of brain-derived neurotrophic factor and nerve growth factor after administration, together with changes in the associated receptor systems. Several authors argue that the peptide acts largely through its degradation products and their interaction with peptidergic pathways, but this remains a hypothesis rather than a settled finding. No single molecular target has been identified in a way that the field broadly accepts.
Material sold for laboratory use varies widely in stated purity and documentation. A certificate of analysis should list the analytical method, the column and detector used, and the observed purity value. Independent verification by an outside laboratory is the practical way to confirm identity when documentation is absent or internally inconsistent. Regulatory status differs by country, and a product legal in one jurisdiction may be unapproved or controlled in another.
Identity and purity of semax are established with reversed-phase high-performance liquid chromatography coupled to ultraviolet detection, usually at 214 nanometres. Mass spectrometry, most often electrospray ionisation in positive mode, confirms the molecular mass and reveals truncated sequences. Amino acid analysis and peptide mapping after enzymatic digestion provide additional structural confirmation. Laboratories typically report purity as the percentage area of the main peak, a figure that does not capture isomeric or oxidised variants unless the method resolves them.
| Property | Value | Notes |
|---|---|---|
| Primary research models | Rodent studies | Largest share of published data |
| Reported markers | BDNF and NGF expression | Measured mainly in animal tissue |
| Common administration | Intranasal | Matches the registered formulation |
| Blood residence time | Minutes | Rapid enzymatic degradation |
| Evidence quality | Small trials, limited replication | Noted repeatedly in reviews |
常规纯度与身份确认依赖反相高效液相色谱，并辅以质谱测定分子量。氨基酸组成分析可用于验证序列构成，肽图分析则能进一步定位修饰或降解产物。杂质谱通常关注缺失序列肽、截短片段和氧化产物。不同方法的检出限并不相同，因此各实验室报告的纯度数值不宜直接横向比较。
多数实验室与市售的 Semax 以冻干粉形式提供。冻干粉通常建议保存在 -20 °C 或更低温度下，同时避免光照与反复升温。短期运输有时采用冷藏条件，但长期保存仍以冷冻为主。分包操作应尽量减少开盖次数，以降低吸湿和微生物污染的风险。开封后若未一次用完，建议在干燥环境中密封并尽快放回低温储存。
溶液状态的稳定性明显低于冻干粉。肽类在水溶液中可能经历水解、氧化与聚集，其中甲硫氨酸和天冬酰胺等残基常是敏感位点。Semax 含有甲硫氨酸，因此氧化风险相对突出。工作液一般主张现配现用，或冷藏并在数日内用尽。缓冲液种类、pH 和离子强度都会影响降解速率，而关于最佳条件的公开数据并不统一。
Quality documentation for research-grade peptide usually includes a certificate of analysis stating purity, identity, and residual counterion content. Batch-to-batch variation in purity and salt form is a recognized issue, and comparisons across suppliers require attention to the exact counterion, for example acetate versus trifluoroacetate. Sequence verification by tandem mass spectrometry provides stronger evidence than a single mass measurement. For any study reporting biological results, the analytical method and the measured purity should be stated explicitly. Independent verification of supplier claims is considered good practice.
Semax is supplied as a lyophilized powder that appears white to off-white. It dissolves readily in water, phosphate-buffered saline, and other aqueous media, which simplifies preparation of working solutions for laboratory use. The nasal products registered in Russia are dilute aqueous solutions, typically around 0.1 percent peptide by weight. Organic solvents are rarely necessary and can complicate handling. Because the peptide is hygroscopic, weighing should be performed quickly and with minimal exposure to ambient humidity.
Solid material is normally kept at minus 20 degrees Celsius in a sealed, desiccated container. Reconstituted solutions are less stable and are usually divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of activity. Light exposure is minimized by using amber glassware or foil wrapping. Published stability data for this peptide are sparse, so recommended storage conditions rest mainly on general practice for short synthetic peptides rather than on dedicated study.
Circulation time for the peptide is short because peptidases cleave it readily. The Pro-Gly-Pro tail is thought to slow breakdown compared with the bare ACTH fragment, but the gain appears modest. Absorption after intranasal dosing is limited, and only a fraction of a dose is expected to reach the central nervous system. Laboratory concentrations therefore sit well above levels achieved systemically, a gap that complicates translation from bench findings to clinical claims.
The mechanisms attributed to semax are inferred from animal and cell studies rather than traced to one confirmed target. The most frequently cited pathway involves increased expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal and cortical tissue. Some work points to engagement of melanocortin receptors, particularly MC4, which the parent ACTH fragment can activate. Effects on dopaminergic and serotonergic signalling have also been reported. No single account explains all observed results, and the relative weight of each pathway remains unsettled.
Published studies examine a fairly narrow set of endpoints. Rodent experiments commonly measure maze learning, infarct volume after induced ischemia, and tissue levels of neurotrophic factors. Clinical reports from Russian centres describe attention, memory and recovery scores in patients after stroke or transient ischemic attack. Most of those human studies are small and few have been repeated by independent groups. Outcome measures differ between studies, which limits direct comparison.
Dissolution is normally performed in water, phosphate-buffered saline, or normal saline, since the peptide is freely soluble in aqueous media and is rarely handled with strong organic solvents. Solution pH should be kept near neutral, because extreme acidity or alkalinity accelerates backbone hydrolysis and encourages oxidation of the methionine side chain. Once dissolved, the material is less stable than the dry powder and is commonly divided into single-use portions and frozen. Buffers containing primary amines, such as Tris, are often avoided because of possible side reactions.
Purity assessment relies mainly on reversed-phase high-performance liquid chromatography, which separates the target heptapeptide from truncated sequences, deletion analogues, and oxidised forms. Mass spectrometry, usually coupled to liquid chromatography, confirms identity through the expected molecular ion and reveals modifications such as methionine sulfoxide formation. Amino acid analysis can verify composition, and tandem mass spectrometry supports sequence confirmation. Ultraviolet detection near 254 to 280 nanometres is convenient because the phenylalanine and histidine residues absorb in that region. Nuclear magnetic resonance is rarely used for routine release testing.
Common degradation pathways include oxidation of the methionine side chain, hydrolysis of the peptide backbone, and aggregation under unfavourable pH or concentration. Stability studies typically monitor the main peak by chromatography and report total related substances as a percentage. Because no official monograph exists, acceptance criteria vary between laboratories, and reported purity values are not directly comparable across suppliers. Analysts therefore document the method, column, and detection wavelength alongside each result, and open questions remain about how much biological activity the oxidised forms retain.
Cultivation of microorganisms does not require fertile soil and therefore does not compete with agriculture. Thanks to the low water requirements, SCP cultivation can even be done in dry climates with infertile soil and may provide a means of fail-safe food supply in arid countries. Photosynthetic microorganisms can reach a higher solar-energy-conversion efficiency than plants, because in photobioreactors supply of water, CO2 and a balanced light distribution can be tightly controlled. Unlike agricultural products which are processed towards a desired quality, it is easier with microorganisms to direct production towards a desired quality. Instead of extracting amino acids from soy beans and throwing away half of the plant body in the process, microorganisms can be genetically modified to overproduce or even secrete a particular amino acid. However, in order to keep a good consumer acceptance, it is usually easier to obtain similar results by screening for microorganisms which already have the desired trait or train them via selective adaptation. Although SCP shows very attractive features as a nutrient for humans, however there are some problems that deter its adoption on global basis:
== Research interests == Jorgenson's research group is focused on utilizing analytical separation techniques to solve research problems in complex mixture analysis. The group currently focuses on ultra-high pressure capillary liquid chromatography combined with mass spectrometry (MS). Jorgenson's research group is best known for their breakthrough in the field of separation sciences, the invention of capillary electrophoresis (CE). He began his research at UNC Chapel Hill studying electro-osmotically driven chromatography. The development of CE has aided in the advancement of many fields of science, including DNA sequencing, forensic DNA analysis and analysis of intact proteins. CE technology enabled completion of the sequencing of the human genome far ahead of the expected schedule and far below anticipated cost. Jorgenson's research group is also notable for some of the earliest demonstrations of the analysis of the contents of single cells, comprehensive two-dimensional separations, and the invention of ultra-high pressure liquid chromatography. His publications in separation methods have been extensively cited. Jorgenson retired in 2019 from the University of North Carolina at Chapel Hill. He was awarded the American Chemical Society Award in Separations Science and Technology.
Narrated by Fisher Dilke, produced by Nick Catliff, made by Lion Television 10 May A Sense of Disaster, about predicting earthquakes; Allan Lindh of the USGS; 17 October 1989 a large earthquake hit California, killing 67 people, with £7bn of damage in the 1989 Loma Prieta earthquake; Chen Li De of China; China predicted earthquakes by radon gas; Huang Xiang Ning, who predicted an earthquake near Tangshan in late July 1976 - the 1976 Tangshan earthquake occurred on 28 July 1976; the Great Hanshin earthquake on 17 January 1995 in Japan, the worst for seventy years in Japan; nuclear physicist Motoji Ikeya of the University of Osaka; geophysicist Joseph Kirschvink of Caltech, who had worked with bees and electromagnetic fields. Narrated by Barbara Flynn, produced by Bill Jones, directed by Chris Malone, made by Granada Television with the Discovery Channel 17 May Deadly Code, about biological weapons and genetic engineering; Vivienne Nathanson of the BMA; ethnic bioweapons; a religious cult leaves nerve gas on Tokyo underground trains in January 1995; Richard A.
A peptidomimetic is a small protein-like chain designed to mimic a peptide. They typically arise either from modification of an existing peptide, or by designing similar systems that mimic peptides, such as peptoids and β-peptides. Irrespective of the approach, the altered chemical structure is designed to advantageously adjust the molecular properties such as stability or biological activity. This can have a role in the development of drug-like compounds from existing peptides. Peptidomimetics can be prepared by cyclization of linear peptides or coupling of stable unnatural amino acids. These modifications involve changes to the peptide that will not occur naturally (such as altered backbones and the incorporation of nonnatural amino acids). Unnatural amino acids can be generated from their native analogs via modifications such as amine alkylation, side chain substitution, structural bond extension cyclization, and isosteric replacements within the amino acid backbone. Based on their similarity with the precursor peptide, peptidomimetics can be grouped into four classes (A – D) where A features the most and D the least similarities. Classes A and B involve peptide-like scaffolds, while classes C and D include small molecules (Figure 1).
Such an inflexible dosing regime limits the utility benzodiazepines offer in practice; e.g. lorazepam and alprazolam can be used as needed for situational anxiety in which continuous use is unnecessary or excessive, while clonazepam can be titrated to response when continuous relief is indicated, up to a maximum of 4 mg a day, four times greater than the dose used in comparison with etifoxine over the 24 week duration of the trial. In general, they offer a degree of personalization that is not possible with etifoxine. Indeed, better evidence is required before etifoxine can be said to replace benzodiazepines in practice, especially considering the trials above were relatively small in size, along with the high attrition rates and lack of personalization of the benzodiazepines used. The usual dosage of etifoxine (as the hydrochloride salt) is 150 to 200 mg per day in divided doses of 50 to 100 mg two to three times per day (e.g., 50 mg–50 mg–100 mg). It is taken for a few days to a few weeks, but no longer than 12 weeks.
Sources: en.wikipedia.org
== Simulators == Simcyp Simulator and GastroPlus (from Simulations Plus) are simulators that take account for individual variabilities. PharmaCalc v02 and PharmaCalcCL allow to simulate individual plasma-concentration time curves based on (published) pharmacokinetic parameters such as half-life, volume of distribution etc.
is obtained. Note, however, that all published dissociation constant values refer to the specific ionic medium used in their determination and that different values are obtained with different conditions, as shown for acetic acid in the illustration above. When published constants refer to an ionic strength other than the one required for a particular application, they may be adjusted by means of specific ion theory (SIT) and other theories.
Many international Hardee's franchises are located in countries in the Middle East and Pakistan, most being owned and operated by Americana Group. The Americana Group opened the Middle East's first Hardee's restaurant in Kuwait in June 1980. As of 2016, there are over 300 Hardee's restaurants throughout Asia and the Middle East, specifically in Bahrain, Egypt, Iraq, Jordan, Kazakhstan, Kuwait, Lebanon, Oman, Palestine, Pakistan, Qatar, Saudi Arabia, United Arab Emirates, and plans to open in Israel. Singapore had a Hardee's franchise first opened in 1984, but the last three outlets closed in 1988. Hardee's opened a store in South Korea in 1990, but it pulled in 2004, due to poor performance. Hardee's also used to operate in Hong Kong, but it pulled out in 2006, due to licensing issues with its US parent. Specifically, in the Middle East, the Hardee's menu does not include any pork items and each beef is certified Halal due to religious and cultural beliefs. The same menu is offered at Hardee's locations in Pakistan, which opened its first location in the country in 2009 in Lahore. Hardee's currently has 18 locations in Pakistan, with six in Lahore, four in Karachi, two each in Islamabad and Rawalpindi and one each in Faisalabad, Bhera, Peshawar and Multan. In 2014, it opened a restaurant in Erbil, Iraqi Kurdistan. There is also a Hardee's location at Jomo Kenyatta International Airport in Nairobi.
First, fluoride can increase the rates of reactions of organotriflates, possibly by the same effect as lithium chloride. Furthermore, fluoride ions can act as scavengers for tin byproducts, making them easier to remove via filtration.
== History == The chemical elements came into being in two phases. The first commenced shortly after the Big Bang. From ten seconds to 20 minutes after the beginning of the universe the earliest condensation of light atoms was responsible for the manufacture of the four lightest elements. The vast majority of this primordial production consisted of the three lightest isotopes of hydrogen—protium, deuterium and tritium—and two of the nine known isotopes of helium—helium-3 and helium-4. Trace amounts of lithium-7 and beryllium-7 were likely also produced. So far as is known, all heavier elements came into being starting around 100 million years later, in a second phase of nucleosynthesis that commenced with the birth of the first stars. The nuclear furnaces that power stellar evolution were necessary to create large quantities of all elements heavier than helium, and the r- and s-processes of neutron capture that occur in stellar cores are thought to have created all such elements up to iron and nickel (atomic numbers 26 and 28). The extreme conditions that attend supernovae explosions are capable of creating the elements between oxygen and rubidium (i.e., atomic numbers 8 through 37). The creation of heavier elements, including those without stable isotopes—all elements with atomic numbers greater than lead's, 82—appears to rely on r-process nucleosynthesis operating amid the immense concentrations of free neutrons released during neutron star mergers.
Sources: en.wikipedia.org
The main proposal is modulation of neurotrophic factors such as brain-derived neurotrophic factor, supported largely by animal experiments. Receptor-level targets have not been firmly established. Most reviews describe the mechanism as only partially characterized.
The compound is registered as a medicine in Russia, so clinical work has concentrated there. Trials elsewhere are few and generally small. This geographic concentration is a recognized limitation in evidence reviews.
Some fraction may reach the central nervous system through olfactory pathways, and this is often cited as the rationale for the nasal route. The size of that fraction in humans is not well quantified. Blood concentrations after nasal dosing are low, which complicates measurement.
Reversed-phase high-performance liquid chromatography is the standard method, with detection in the ultraviolet range. Peak area percentage yields a purity figure for the main component. Mass spectrometry is normally run alongside to confirm molecular identity.